2. 您的位置
3. 首页
4. 会议论文
5. GluN2B Antagonists-Are They Good for Treating Alzheimer's Disease

GluN2B Antagonists-Are They Good for Treating Alzheimer's Disease

来源 :2015第三届世界健康大会、首届国际失智症大会、第三届国际老年病学大会、第四届国际糖尿病学大会暨第五届国际内分泌与代谢大 | 被引量 : 0次 | 上传用户：gzlwh

【摘 要】

：

　　Extensive evidence implicates GluN2Bcontaining NMDA receptors (GluN2BNMDARs) in excitotic-insult-induced neurodegeneration and amyloid β-induced synaptic d

【作 者】

：

Qiang Zhou 

【机 构】

：

Peking University Shenzhen Graduate School China

【出 处】

：

2015第三届世界健康大会、首届国际失智症大会、第三届国际老年病学大会、第四届国际糖尿病学大会暨第五届国际内分泌与代谢大

【发表日期】

：

2015年期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Extensive evidence implicates GluN2Bcontaining NMDA receptors (GluN2BNMDARs) in excitotic-insult-induced neurodegeneration and amyloid β-induced synaptic dysfunctions, suggestive of their potential in treating Alzheimer's disease.

其他文献

Disease Modifying Trials in Alzheimer

　　The nature of Alzheimer's disease and its increasing prevalence, types and main findings of 15 years of clinical research history will be reviewed.Summary o

会议

Proposal of MedicoMusik:Trinity of Musicology, Engineering,and Medicine

　　Dementia is already a critical issue in the super-aging society.Toward effective prevention and rehabilitation of dementia, we have explored better music th

会议

The Role a Dementia Care Consultant in Moving a Dementia Fearful Community to a Dementia Friendly Co

　　In 2014, the Bethanie Group, the largest not for profit Western Australian provider of residential,retirement living and community aged care services, intro

会议

Microchimerism and Neurodegenerative Disorders

　　Neurodegenerative diseases are a health problem that is growing.Among these diseases,Alzheimer's disease and Frontotemporal dementia, are particularly impor

会议

Alzheimer's Disease Biomarker of Aβ 42, Tau and Phospho-tau Study on the Australian Imaging Bio

　　The cerebrospinal fluid (CSF) Aβ 42, tau (T-tau) and phosphorylated-tau (at serine 181;P-tau) profile is established as a valuable biomarker for Alzheimer'

会议

Brain Development, Aging and Dementia Using Large Brain MRI Database

　　Now we confront a super aging society in Japan.In the situation, it is important to preserve our cognitive function for entire life by preventing us from pa

会议

Novel NMDA Modulation for Alzheimer's Disease

　　The prevalence of dementia increases rapidly worldwide.The high morbidity and mortality of dementia in the aging population add heavy burden to the society.

会议

Is AD a Medical Notion of Dementia Worth Keeping in Clinical Practice

　　AD started from 1910.Its diagnosis varies from senile dementia to senium praecox to MCI leading to AD as the most feared form of dementia.The guidelines of

会议

Hyperphosphorylated Tau as a New Target for Alzheimer's Disease Drug Discovery

　　Neurofibrillary tangles (NFTs) are a key biomarker for Alzheimer's disease (AD) and other tauopathies.NFTs are comprised primarily of hyperphosphorylated ta

会议

Comprehensive Studies on Early Diagnosis and Progression Monitor of Prodromal Alzheimer Disease: Pla

　　Comprehensive studies for identifying normal subjects and individuals with MCI due to AD or early-stage AD by medical imaging and plasma biomarker assays ar

会议